Home › Schildklierkanker › Texas › Houston
Schildklierkanker klinische studies in Houston, TX
12 studies voor Schildklierkanker zoeken deelnemers op locaties in en rond Houston (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- UT MD Anderson Cancer Center, Houston
Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
RekruterenObservatieonderzoek
- MD Anderson Cancer Center, Houston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RekruterenFase 1/2
- MD Anderson Cancer Center, Houston
Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
Rekruteren
- The University of Texas M. D. Anderson Cancer Center, Houston
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
RekruterenFase 2
- MD Anderson Cancer Center, Houston
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
RekruterenFase 2
- MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruterenFase 1/2
- MD Anderson Cancer Center, Houston
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
RekruterenFase 1Gezonde vrijwilligers welkom
- M D Anderson Cancer Center, Houston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RekruterenFase 1/2
- MD Anderson Cancer Center, Houston
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Rekruteren
- M D Anderson Cancer Center, Houston
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
RekruterenFase 2
- MD Anderson Cancer Center, Houston
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
RekruterenFase 2
- MD Anderson Cancer Center, Houston
Schildklierkanker studies in andere steden
- Washington, DC10 studies
- New York City, NY9 studies
- Boston, MA6 studies
- Philadelphia, PA6 studies
- Nashville, TN5 studies
- Durham, NC5 studies
- Los Angeles, CA5 studies
- San Francisco, CA4 studies
- San Antonio, TX4 studies
- Minneapolis, MN4 studies
- St. Louis, MO4 studies
- Memphis, TN4 studies
Andere studies in Houston
- Niet-kleincellige longkanker145 studies
- Borstkanker126 studies
- Kanker (alle vormen)121 studies
- Metastatische kanker104 studies
- Colorectale kanker102 studies
- Eierstokkanker89 studies
- Acute myeloïde leukemie85 studies
- Longkanker78 studies
- Prostaatkanker76 studies
- Endometriumkanker68 studies
- Aldermeesklierkanker61 studies
- Melanoom59 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.